In order to address this issue we treated cells with 3BrP (concentrations in the range used in cancer research—0–80 mM [43]) in the presence of LIF, and monitored changes in mESC pluripotency to determine if 3BrP would induce metabolic changes that might shift cells towards differentiation, even under stringent pluripotency conditions. This evidence concerns the gene LIF and cancer.